Insider trade

ADMA Biologics, Inc. (ADMA)Director sold ~$158K

Lawrence P. Guiheen, Director at ADMA Biologics, Inc., sold ~$158K of ADMA Biologics, Inc. shares.

~$158K
Approx. value · 7,779 sh @ $20.32: 115K
Holds after · shares reported

Traded: May 21, 2025
Filed: May 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 19, 2025Insider · 1 personInsiders: 2 sales (~$397K)
Apr 15, 2025Insider · 1 personInsiders: 2 sales (~$451K)
May 15, 2025Insider · 1 personInsiders: 2 sales (~$408K)
May 21, 2025 · this disclosureInsiderDirector sold ~$158K of ADMA shares in the open market

What came next

May 22, 2025InsiderDirector sold ~$25K of ADMA shares in the open market
Jun 9, 2025Insider · 2 peopleInsiders: 2 sales (~$632K)
Jun 12, 2025InsiderDirector sold ~$2.02M of ADMA shares in the open market
Jun 13, 2025InsiderDirector sold ~$2.87M of ADMA shares in the open market
Jun 16, 2025Insider · 2 peopleInsiders: 3 sales (~$4.4M)
Jul 15, 2025Insider · 1 personInsiders: 2 sales (~$392K)
Aug 15, 2025Insider · 1 personInsiders: 2 sales (~$354K)
Sep 15, 2025Insider · 1 personInsiders: 2 sales (~$339K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ADMA Biologics, Inc.

For ADMA Biologics, Inc., OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADMA page.

Other recent filings by Lawrence P. Guiheen, Director

The full history of Lawrence P. Guiheen, Director is on the profile page.

How this filing works

Other disclosures at ADMA Biologics, Inc.

Everything OQRO holds on this company is on its ADMA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data